Love to see these familiar faces! Congrats Deepak, Hannah and Giulia! #GI24

From CANCER STATISTICS 2024: Importance of studying early onset #ColorectalCancer 👉🏽 Mortality rates from this disease overall have steadily dropped. However: In men under 50 #ColorectalCancer is now the number ONE cause of cancer related deaths. In women under 50,

Olanzapine showed benefit (pts gained >5% wt); another study showed decreased nausea/vomiting, increased appetite and sense of well-being... while mirtazapine has negative data. #GI24 Rajiv Agarwal MD

Ensuring patients with #cancer are well-informed about clinical trials is crucial! Proud to share our JAMA Oncology patient page, dedicated to ⬆️ inclusion & diversity in trial enrollment—#patienteducation is an important first step! 👥🔗 jamanetwork.com/journals/jamao… OncoAlert #lcsm

Congratulations to all the AACR 2024 Scientific Award Recipients!!! 🙌🏽 Especially proud about these two MD Anderson Cancer Center awardees - Scott Kopetz and Elizabeth Travis,PhD aacr.org/about-the-aacr… How fitting for Scott to win the award named after Waun Ki Hong. And Liz is of course a

Happening now at #AACR24: Dr. Scott Kopetz, AACR Waun Ki Hong Award recipient, is giving a lecture on Adaptive Resistance in BRAF- and KRAS-mutated #ColorectalCancer. Scott Kopetz #EndCancer

Ready for #ASCO24 and #colorectalcancer day!

#ASCO24 is all about branching out from your subspecialty because knowledge conquers cancer! Madhu Eluri, MD presenting exciting work in the colorectal cancer space!! 🔥MD Anderson Cancer Center #EndCancer

In light of @ccaalliance #YoungSurvivorsWeek, a summary of the American Cancer Society paper on colorectal cancer trends in the United States and the rise of young-onset CRC. Full article here: acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca… #crcsm #ayacsm

Thank you #ASCO24 for another year of discovery and for connecting with friends and colleagues old and new!

#OpenAccess in Nature Medicine Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic #ColorectalCancer: a phase 1 trial nature.com/articles/s4159… This paper is generating a lot of excitement because of MSS CRC, but important to remember that

Houston continues to remain without power on Day 2 of #HurricaneBeryl and no sight of CenterPoint Energy. Hope everyone stays safe!

Random catch ups with Eric K. Singhi, MD are the best!